Abstract
Target engagement measurements are critical for evaluating developmental drug candidates and their pharmacological activity. microRNA (miRNA) Polysome Shift Assay enables measurement of anti-miR drug target engagement (i.e. extent of miRNA inhibition) without the need to pre-identify or pre-validate downstream miRNA-regulated genes. This makes it useful for assessing anti-miR activity in target tissues or cells where biology of the inhibited miRNAs may not be well understood. In addition, miRNA Polysome Shift Assay can be multiplexed to assess inhibition of multiple miRNAs by a single anti-miR, thus guiding drug optimization for enhancing or avoiding these activities as desired. This chapter outlines the miRNA Polysome Shift Assay technique, describes sample preparation and quality control, and how to calculate and interpret results.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Androsavich JR, Sobczynski DJ, Liu X, Pandya S, Kaimal V, Owen T, Liu K, MacKenna DA, Chau BN (2015) Polysome shift assay for direct measurement of miRNA inhibition by anti-miRNA drugs. Nucleic Acids Res 2015:gkv893. doi:10.1093/nar/gkv893
Androsavich JR, Chau BN, Bhat B, Linsley PS, Walter NG (2012) Disease-linked microRNA-21 exhibits drastically reduced mRNA binding and silencing activity in healthy mouse liver. RNA 18(8):1510–1526. doi:10.1261/rna.033308.112
Maroney PA, Yu Y, Fisher J, Nilsen TW (2006) Evidence that microRNAs are associated with translating messenger RNAs in human cells. Nat Struct Mol Biol 13(12):1102–1107, doi:nsmb1174 [pii] 10.1038/nsmb1174
Nottrott S, Simard MJ, Richter JD (2006) Human let-7a miRNA blocks protein production on actively translating polyribosomes. Nat Struct Mol Biol 13(12):1108–1114, doi: nsmb1173 [pii] 10.1038/nsmb1173
Molotski N, Soen Y (2012) Differential association of microRNAs with polysomes reflects distinct strengths of interactions with their mRNA targets. RNA 18(9):1612–1623. doi:10.1261/rna.033142.112
Gandin V, Sikström K, Alain T, Morita M, McLaughlan S, Larsson O, Topisirovic I (2014) Polysome fractionation and analysis of mammalian translatomes on a genome-wide scale. J Vis Exp 87:PMID:24893926. doi:10.3791/51455
Noll H (2008) The discovery of polyribosomes. Bioessays 30:1220–1234
Stenvang J, Petri A, Lindow M, Obad S, Kauppinen S (2012) Inhibition of microRNA function by antimiR oligonucleotides. Silence 3(1):1. doi:10.1186/1758-907X-3-1
Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M (2005) Silencing of microRNAs in vivo with ‘antagomirs’. Nature 438(7068):685–689. doi:10.1038/nature04303
Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3(6):1101–1108
Acknowledgement
This work was developed by Regulus Therapeutics Inc., which employed the author.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Androsavich, J.R. (2017). Assessing Anti-miR Pharmacology with miRNA Polysome Shift Assay. In: Schmidt, M. (eds) Drug Target miRNA. Methods in Molecular Biology, vol 1517. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6563-2_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6563-2_7
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6561-8
Online ISBN: 978-1-4939-6563-2
eBook Packages: Springer Protocols